Copied
 
 
Formål
Formål
Selskabets formål er at foretage salg og udvikling af lægemidler, behandlinger og medicinsk udstyr til brug globalt, samt andre aktiviteter der står i forbindelse hermed.
Sidst opdateret den 13.07.2017 og angivet som gældende fra 12.07.2017 (2489 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 13.07.2017 og angivet som gældende fra 12.07.2017 (2489 dage).
Ingen historik.
Branche
Branche
Fremstilling af farmaceutiske præparater (212000).
Sidst opdateret den 13.07.2017 og angivet som gældende fra 12.07.2017 (2489 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 09.01.2024 og angivet som gældende fra 21.12.2023 (136 dage).
HistorikStartStop
false21.12.2023
true12.07.201720.12.2023
Revisor
Revisor
GILFELT REVISION REGISTRERET REVISIONSANPARTSSELSKAB
Sidst opdateret den 09.01.2024 og angivet som gældende fra 21.12.2023 (136 dage).
Ingen historik.
Form
Virksomhedsform
60.
Sidst opdateret den 09.01.2024 og angivet som gældende fra 21.12.2023 (136 dage).
HistorikStartStop
6021.12.2023
8012.07.201720.12.2023
Kontakt
Kontaktoplysninger
cm@inphena.com.
Sidst opdateret den 16.10.2023 og angivet som gældende fra 16.10.2023 (202 dage).
HistorikStartStop
cm@inphena.com16.10.2023
san@inphena.com12.07.201715.10.2023
Telefon
Telefonnummer
71747174.
Sidst opdateret den 16.09.2019 og angivet som gældende fra 16.09.2019 (1693 dage).
Ingen historik.
Navne
Binavne
Binavne
CPH.BIO A/S.
Sidst opdateret den 09.01.2024 og angivet som gældende fra 09.01.2024 (117 dage).
HistorikStartStop
CPH.BIO A/S09.01.2024
Copenhagen Bio A/S09.01.2024
Inphena Biotech A/S09.01.2024
Inphena Pharma A/S09.01.2024
CPH.BIO ApS26.09.201908.01.2024
Copenhagen Bio ApS26.09.201908.01.2024
Inphena Biotech ApS12.07.201708.01.2024
Inphena Pharma ApS12.07.201708.01.2024
Tegningsregel
Tegningsregel
Selskabet tegnes af den administrerende direktør eller den samlede bestyrelse.
Sidst opdateret den 29.03.2023 og angivet som gældende fra 29.03.2023 (403 dage).
Fortolkning (2 tegningsmuligheder)
direktøren
bestyrelsen
HistorikStartStop
Selskabet tegnes af den administrerende direktør eller den samlede bestyrelse29.03.2023
Selskabet tegnes af bestyrelsesformanden eller den samlede bestyrelse06.12.201728.03.2023
Selskabet tegnes af bestyrelsesformanden eller den samlede bestyrelse12.07.201705.12.2017
Ansatte
05.05.2024
Kapital
05.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Gilfelt Revision ApS
Revisionsvirksomhedens CVR-nr.:28108303
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis of opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibility under those standards and requirements are further described in the “Auditors' responsibility for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code) together with the ethical requirements that are relevant to our audit of the financial statement in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion We have audited the financial statements of Inphena A/S for the financial year 1 January 2023 - 31 December 2023, which comprise an income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2023 and of the results of its operations for the financial year 1 January 2023 - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management's Review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of opinion providing assurance regarding the Management's review. Our responsibility in connection with our audit of the financial statements is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or with the knowledge we have gained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review meets the disclosure requirements in the Danish Financial Statements Act. Based on our procedures, we are of the opinion that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements in the Danish Financial Statements Act. In our opinion, the Management's review is not materially misstated. , Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of opinion providing assurance regarding the Management's review. Our responsibility in connection with our audit of the financial statements is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or with the knowledge we have gained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review meets the disclosure requirements in the Danish Financial Statements Act. Based on our procedures, we are of the opinion that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements in the Danish Financial Statements Act. In our opinion, the Management's review is not materially misstated.
Bibranche
Bibranche
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil.
Sidst opdateret den 13.07.2017 og angivet som gældende fra 12.07.2017 (2489 dage).
Ingen historik.
Børsnoteret
05.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
05.05.2024
Hjemmeside
www.inphena.com.
Sidst opdateret den 14.11.2018 og angivet som gældende fra 14.11.2018 (1999 dage).
Ingen historik.